background: PGD has been described in previous cross-sectional and retrospective studies as a stressful experience. No prospective studies of the psychological impact of PGD are currently available.
Introduction
PGD is an assisted reproductive technique (ART) used by couples at increased risk of having a child with a genetic condition. It involves the use of IVF to produce embryos that are genetically tested and selected based on the absence of particular genetic conditions. The embryo is then transferred into the uterus with the aim of establishing a pregnancy of a healthy biologically related child. PGD was first reported as successful in humans in the early 1990s (Handyside et al., 1990) ; two decades later, the psychological impact of PGD has not yet been clearly defined. A recent review of literature related to the psychosocial impact of PGD by Karatas et al. (2010a) concluded that the current research focuses on attitudes of genetically at-risk couples for whom PGD may be beneficial, and the results suggest that those with traumatic reproductive and genetic histories are more likely to find PGD an acceptable treatment option. In addition, a small number of studies have investigated samples of women who have actually used PGD, though these are all retrospective or cross-sectional in design (Katz et al., 2002; Lavery et al., 2002; Roberts and Franklin, 2004; Kalfoglou et al., 2005) . The general lack of homogeneity in the methods used and the scope of these studies contribute to their inconsistent findings on the psychosocial experience of PGD. To our knowledge, a prospective study of women undergoing PGD that utilizes validated psychometric scales has not yet been conducted. This study was undertaken to address this gap in the literature and reports on findings from a prospective study of a sample of Australian women using PGD. The baseline data collected prior to the commencement of IVF and PGD treatment has been reported elsewhere (Karatas et al., 2010b) .
The formulation of hypotheses to be tested by this study was informed by our previous qualitative study on the psychological experience of PGD (Karatas et al., 2010c) . The psychological impact of IVF has been extensively researched and, as PGD requires the use of IVF, the findings identified in two recent reviews of psychosocial adjustment in women undergoing IVF treatment (Verhaak et al., 2007) and women pregnant after conceiving through ART were also used to guide the current study.
Anxiety and depression during IVF cycles
Fluctuation in anxiety levels at crucial stages in the IVF process has been reported. Four studies followed-up women around the time of embryo transfer (Merari et al., 1992; Ardenti et al., 1999; Yong et al., 2000; Klonoff-Cohen et al., 2001) . In addition to measuring outcomes around the time of embryo transfer, two studies assessed outcomes around the time of pregnancy testing (Merari et al., 1992; Klonoff-Cohen et al., 2001) . One additional study (Boivin and Takefman, 1995) used a daily record-keeping sheet (Takefman et al., 1992) , an instrument used to measure daily levels of emotional, physical and behavioral reactions during the IVF cycle. On the basis of the findings from these studies that measured the fluctuation of anxiety and depression within one IVF cycle, the stressors of the process appear to provoke a significant emotional response from women, compared with baseline measures prior to treatment. The periods most likely to cause the highest distress are around the time of oocyte retrieval (Merari et al., 1992; Ardenti et al., 1999) , embryo transfer (Ardenti et al., 1999; Klonoff-Cohen et al., 2001 ) and pregnancy testing (Merari et al., 1992; Yong et al., 2000) . It is expected that similar fluctuations in anxiety at key stages during treatment will be seen in the PGD sample. In addition, a rise in depression symptoms might be expected as an emotional reaction of women who have proceeded to embryo transfer, yet upon pregnancy testing find out that a pregnancy was not established. Thus, following receipt of pregnancy test results, it is expected that women who are not pregnant have higher depression scores than those who achieved a pregnancy.
Pregnancy
A second group of studies identified in a review by Hammarberg et al. (2008) examined psychological wellbeing in women who achieve a pregnancy through IVF. Studies exploring anxiety in pregnancy using global measures have generally not reported significant differences between women who underwent IVF and naturally conceiving controls (Reading et al., 1989; Stanton and Golombok, 1993; McMahon et al., 1997 McMahon et al., , 2007 Klock and Greenfeld, 2000; Hjelmstedt et al., 2003; Cox et al., 2006; Harf-Kashdaei et al., 2007) . However, studies examining pregnancy-specific anxiety have found significant differences between women using IVF and their natural conception control groups. For example, McMahon et al. (1997) utilized the Baby Schema (a scale assessing pregnancy-specific anxieties) and found that women using IVF had significantly higher scores on 'anxieties concerning health and defects in the child'. More recently, Hjelmstedt et al. (2003) developed a scale called the emotional response to pregnancy scale, based on ideas from the Baby Schema, and found women using IVF reported significantly more anxiety about losing the pregnancy, though they were less anxious about the baby not being healthy, compared with those who had conceived naturally.
Evidence is consistent that depression in pregnancy is not increased in women using IVF (Klock and Greenfeld, 2000; Hjelmstedt et al., 2006; Harf-Kashdaei et al., 2007; McMahon et al., 2007) . Indeed, two studies found IVF women reported significantly lower levels of depression than natural conception controls (Repokari et al., 2005) and community normative data (Repokari et al., 2005; Fisher et al., 2008) . Fisher et al. (2008) suggested that the low levels of depression in their sample may have been due to the psychosocial protective factors characterizing IVF women in their sample who were disproportionately highly educated, socioeconomically advantaged and reported intimate relationships as supportive and sensitive. Additionally, Fisher et al. (2008) noted that women conceiving through IVF have achieved a much desired pregnancy and were likely to be elated at the pregnancy state and family formation.
In terms of maternal-fetal attachment in pregnancy following IVF, research to date has not identified significant differences between women who used IVF to establish a pregnancy and women who conceived naturally (cf. Hammarberg et al., 2008 , for systematic review; Stanton and Golombok, 1993; McMahon et al., 1997; Hjelmstedt et al., 2006) . A study by Stanton and Golombok (1993) was based on a small sample size and used the maternal-fetal attachment scale (MFAS; Cranley, 1981) ; the validity of this scale has been questioned with suggestions that the MFAS measures attitude to the state of pregnancy, rather than attachment to the fetus per se. Two Australian studies by Fisher et al. (2008) and McMahon et al. (1997) used the attachment scale developed by Condon (1993) , known as the 'Antenatal Attachment Questionnaire' (AAQ). This measure is more informative because it explores 'quality of attachment' and 'time spent in attachment mode'. Normative data for Australian women who have conceived naturally are available. In both studies, no differences were found between women using IVF and a naturally conceiving control group (McMahon et al., 1997) or normative data at 30 and 32 weeks gestation, respectively. Similarly, it is hypothesized that the women in the current sample will have levels of attachment comparable to normative data.
Hypotheses
The study had three main aims: the first was to describe the pathway through treatment for women having PGD; the second was to assess changes in mood across different time points in this treatment pathway and the third was to explore maternal-fetal attachment for those women achieving a pregnancy. The empirical evidence on the psychological impact of IVF described above provides the foundation for the research hypotheses. All hypotheses were formulated before undertaking any significance testing (see Fig. 1 for assessment structure):
1. Following embryo transfer (T2): a. Mean state anxiety scores will be higher than at baseline (T1); b. Mean depression scores will not be different to baseline data (T1).
Following pregnancy result notification (T3):
a. Mean state anxiety scores will be higher following pregnancy test notification (T3) than at baseline (T1), regardless of pregnancy test outcome; b. Mean changes in state anxiety scores from baseline (T1) will be higher in women with negative pregnancy test results than in women with positive pregnancy results;
Emotional responses in women using PGD c. Mean changes in depression scores from baseline (T1) will be higher in women with negative pregnancy test results than in women with positive pregnancy results. d. For women who achieve a pregnancy, at 24 weeks of pregnancy (T4), mean anxiety and depression scores will not differ from baseline (T1) scores. e. At 24 weeks of pregnancy (T4), maternal attachment to the fetus will not differ from normative data.
Materials and Methods

Participants and recruitment procedure
Women were considered eligible to participate if they were pursuing PGD treatment, were aged 18 and over and had a command of the English language adequate to provide informed consent and complete the questionnaires. All women were recruited through a private IVF/PGD clinic in Sydney, Australia. Ethics approval was obtained from all relevant Institutional Ethical Review Boards. Couples were mailed an information package to read prior to attending their first appointment at the clinic. The couples' first appointment at the clinic involved meeting with a PGD nurse coordinator, who was responsible for asking women if they had received and read the study information sheet and if they would be interested in obtaining more information about the study. The contact details of the women who agreed to receive more information were sent to the research coordinator (based off-site) who then sent a more detailed information sheet, a consent form, the first questionnaire and a reply paid envelope. If the woman chose to participate in the study, she was instructed to sign the consent form, complete the first questionnaire and return both in the reply paid envelope. Women who did not return the questionnaire were telephoned to ascertain whether the study package had been received; and if not, it was resent. As noted in the consent form, providing consent to participate in the study included allowing the researcher access to treatment outcome information via the PGD nurse coordinator. Participant enrollment occurred upon receipt of the completed consent form and first questionnaire and their progress was monitored through the stages of PGD including embryo transfer dates and outcome of pregnancy testing by the research coordinator, who liaised with the PGD nurse coordinator at the clinic.
Assessment Structure
There were four follow-up timepoints at which the women were assessed via questionnaire (see Fig. 1 for diagrammatic representation of assessment structure) including the numbers of women who completed each of the four study questionnaires:
1. After initial consultation at the clinic and decision made to pursue IVF and PGD (T1); 2. Within 5 days of embryo transfer (T2); 3. Within 1 week of pregnancy result notification, both positive and negative (T3); 4. 24 weeks of pregnancy, for those who achieved a pregnancy (T4).
Measures
Women completed the following measures (as well as other surveys and questions, reported elsewhere Karatas et al., 2010b) at baseline data collection:
Demographic characteristics. Age, employment, current marital status, highest level of education obtained, level of household income, religion, languages spoken at home and type of living location (metropolitan, rural etc.). Reproductive and genetic history. Number and outcome of previous pregnancies; number of living affected and unaffected children; previous use of prenatal tests, IVF and PGD and family history of genetic conditions. The following measures were administered at all four timepoints:
State anxiety. The Spielberger state anxiety inventory, a widely used and validated scale, consists of a 20-item scale that measures state anxiety (e.g. 'how you feel right now?'; Spielberger 1983) . Each item has four response options yielding a score between 20 and 80, with higher scores indicating higher state anxiety. A cut-off score of 40 and above being indicative of clinically significant anxiety has been validated for Australian childbearing women (Barnett and Parker, 1986; Grant et al., 2008) . Hospital anxiety and depression scale: depression subscale. The hospital anxiety and depression scale has two 7-item subscales used to screen for anxiety and depression symptomatology (Zigmond and Snaith, 1983) . Only the depression subscale was employed, which consists of questions with three Likert-style response options (e.g. 'I feel cheerful') that yield a total score of 0 to 21. Scores of ≥8 represent elevated depression, and scores of ≥11 indicate potentially clinically significant depression (Zigmond and Snaith, 1983) .
During pregnancy, measures used were:
Antenatal Attachment Questionnaire. This scale, developed by Condon (1993) , measures maternal attachment and consists of 19 items and responses rated on a 5-point Likert-type scale. Normative data on Australian samples are available. The scale has demonstrated good internal consistency, a good spread of scores and a sound factor structure (Condon, 1993) . This scale has been used in two previous Australian studies exploring attachment to fetus following IVF conception (McMahon et al., 1997; Fisher et al., 2008) . The scale consists of two factors: quality of attachment (e.g. 'Over the past two weeks when I have spoken about, or thought about the developing baby, I got emotional feelings which were'; response options range from: 'very weak or non-existent' to 'very strong') and time spent in attachment mode (e.g. 'The past two weeks I have thought about, or been preoccupied with the developing baby'; response options range from: 'almost all the time' to 'not at all').
Data analysis
Data were explored initially with descriptive statistics and graphs, and normality of outcome variables was checked. State anxiety was normally distributed and depression scores were non-normally distributed.
To test hypotheses 1a, 1b, 2a and 3, for the normally distributed variable, anxiety, paired sample t-tests were used, and for the non-normally distributed variable, depression, the related sample Wilcoxon signed-rank pairs were used.
To test hypotheses 2b and 2c, change scores were calculated from baseline (T1) to following pregnancy result notification (T3). Independent sample t-tests were used to assess differences in change scores between women with a positive pregnancy result compared with those with a negative pregnancy result.
To test hypothesis 4, confidence intervals were calculated to ascertain whether statistical differences existed between scores in this sample compared with normative data.
Results
PGD pathway and outcome
From July 2006 to October 2009, 87 eligible women were invited to the study; of these, 50 women returned the baseline questionnaire (response rate 57%, Fig. 1 ). Demographic and reproductive histories of participants are summarized in Table I . As presented in Fig. 1 , of these 50 women, 39 women reached embryo transfer. Owing to the strict time frame in which to follow women up, only 26 of these women were sent questionnaire 2 at Time 2 (within 5 days of embryo transfer); of these, 19 women (38% of total sample) returned questionnaire 2. The 39 subsequently had pregnancy testing and returned the Time 3 (within 1 week of pregnancy result notification) questionnaire following a positive pregnancy test (n ¼ 21) or a negative pregnancy result (n ¼ 10), or some women were lost to follow-up at this time. Of the 22 women who established a pregnancy and reached 24 weeks at the study completion, 21 women returned questionnaire 4 at Time 4 (24 weeks of pregnancy). Table II reports on the outcomes of PGD for the women enrolled in this study. Figure 2 represents the linear pathways to establishing a pregnancy following PGD. It became apparent, from following the women up at the several time points, that there were many instances when women may deviate from this linear pathway and encounter barriers to successful embryo transfer and pregnancy and that the pathways were more cyclical than linear.
For the women in this sample, examples of failed attempts at establishing a pregnancy following PGD included: not having embryos suitable for testing (n ¼ 13), not having any embryos suitable for transfer after genetic testing (n ¼ 10) or not establishing a pregnancy following embryo transfer (n ¼ 52), as more than one transfer not leading to pregnancy for each woman was possible. Where there were frozen embryos, these were often used for frozen embryos transfers, though in some cases thawing was unsuccessful (n ¼ 3). Where no frozen embryos were available, this frequently led the women/couple to consider another full stimulation cycle. Additionally, in three cases, women attempting a new cycle had to cancel the cycle due to the risk of ovarian hyper-stimulation syndrome.
Prospective questioning at four time points
Mood state
The observed mean anxiety and depression scores, range of scores, percentages and numbers of women scoring above the published cut-off levels for each follow-up time point can be seen in Table III . Figures 3 and 4 represent the changes in anxiety and depression scores, respectively, over time separately for women who did and did not achieve a pregnancy.
Anxiety
As predicted in hypothesis 1a, there was a significant increase in anxiety from baseline (T1) to post-embryo transfer (T2) (t ¼ 23.44, df ¼ 18, P ¼ 0.003). Also, as predicted in hypothesis 2a, there was a significant increase in anxiety from baseline (T1) to post-pregnancy test result (T3) for both groups of women; those who received a positive pregnancy result and therefore achieved a pregnancy (t ¼ 2.50, df ¼ 19, P ¼ 0.02), and those who received a negative result and thus did not achieve a pregnancy (t ¼ 23.67, df ¼ 10, P ¼ 0.004).
Contrary to what was predicted in hypothesis 2b, no significant differences in anxiety change scores from baseline (T1) to postpregnancy result (T3) were found, when comparing women who received a positive pregnancy result with those who received a negative result (t ¼ 0.55, df ¼ 29, P ¼ 0.58).
Emotional responses in women using PGD As predicted in hypothesis 3, no significant changes were observed in anxiety scores between baseline (T1) and 24 weeks of pregnancy (T4) (t ¼ 0.45, df ¼ 20, P ¼ 0.65).
Depression
As predicted in hypothesis 1b, depression scores did not increase significantly from baseline (T1) to post-embryo transfer (T2) (Wilcoxon test statistic ¼ 1.56, P ¼ 0.11). Contrary to what was hypothesized in 2c, no significant differences in depression change scores from baseline (T1) to post-pregnancy result (T3) were observed between women who received a negative pregnancy result and those who received a positive result (t ¼ 20.53, P ¼ 0.59). As predicted in hypothesis 3, no significant changes were observed in depression scores between baseline (T1) and 24 weeks of pregnancy (T4) Antenatal attachment in pregnancy Figure 5 summarizes the data from the PGD participants and two reference groups, data from a normative Australian sample of women who conceived naturally measured at on average 32 weeks of pregnancy (Condon, 1993) and data from a recent prospective Australian study of 166 women conceiving through IVF measured at 32 weeks pregnancy . The table/figure shows that the confidence intervals (CI) for the mean attachment global, quality and time AAQ scores in our sample were very similar and overlapped with those calculated for the normative data, indicating that there was no evidence that maternal antenatal attachment to the fetus differs between women who used either PGD or natural conception to establish a pregnancy.
In contrast, the global AAQ score in the PGD sample was significantly lower than the AAQ score reported for the sample who underwent IVF only , indicating lower attachment in the PGD sample, compared with the IVF sample. The time spent in the Emotional responses in women using PGD attachment mode subscale was also greater in the women using IVF only, compared with the current PGD sample. However, the PGD and IVF samples did not differ significantly for the AAQ quality of attachment.
Discussion
The pathway to pregnancy using PGD is sometimes convoluted and can involve multiple full stimulation cycles and embryo transfers before success is achieved, if at all. Overall, the findings of this study show similar patterns of adjustment during treatment to those reported in women conceiving through IVF; however, some interesting differences emerge with respect to fetal attachment for those women who achieved a pregnancy using PGD. As predicted, anxiety significantly increased following embryo transfer. Interestingly, anxiety also significantly increased following pregnancy test notification, regardless of whether the result was positive or negative. Women who received negative pregnancy results were not significantly more anxious than women who achieved a pregnancy. At 24 weeks of pregnancy, anxiety levels had returned to baseline levels. These findings are similar to those from studies assessing the experiences of women who have used IVF during treatment, where significant increases from baseline in anxiety were seen around the time of embryo transfer, using measurements taken at the first visit and before treatment (Ardenti et al., 1999; Yong et al., 2000; KlonoffCohen et al., 2001) or prior to oocyte retrieval (Merari et al., 1992) .
Levels of depression did not fluctuate significantly over the course of PGD, though this may be due to limited power, given the relatively small sample size. These findings are similar to research conducted on women using IVF alone, where very low levels of depression have been observed; as discussed above, this may be due to the presence of protective psychosocial factors. For example, as delineated in our previous publication of baseline data (Karatas et al., 2010b) , women in this study on average had high annual household incomes and the majority were university and postgraduate educated. Another explanation for low depression levels in pregnancy following assisted reproduction put forward by Fisher et al. (2008) can also be applied to women who fall pregnant as a result of undergoing PGD; specifically women have expended high levels of resources (energy, Figure 4 Depression scores over time, separately for women with positive and negative pregnancy test results. Figure 5 Confidence intervals for the AAQ global scores, as well as the two subscale scores, for women who had used the following methods of conception: PGD, IVF, and natural conception (control). PGD: this study sample n ¼ 21, assessed at 24 weeks gestation; IVF: sample from study by Fisher et al. (2008) , n ¼ 166, sample assessed at 32 weeks gestation; Norm: sample from study by Condon (1993) , n ¼ 122, assessed at 32 weeks gestation; AAQ global, global attachment score; AAQ qual, the quality of attachment subscale score; AAQ time, time spent in attachment mode subscale score. time, finances) to establish a pregnancy and thus are likely to experience elation related to the pregnancy state.
Despite the reproductive trauma often experienced by women prior to commencing PGD and the complex nature of establishing a pregnancy, at 24 weeks gestation the women had antenatal attachment levels comparable to normative data reported by Condon (1993) .
However, differences in attachment were observed between women using PGD and women who had used IVF. For example, overall antenatal attachment scores, as well as scores for the time spent in attachment mode subscale of the AAQ, were significantly higher in Australian women who underwent IVF . These lower levels of attachment may be due to the differences in gestational age when women were assessed. Two studies reported an increase in maternal-fetal attachment over the course of pregnancy, indicating that attachment is a developmental process (Hjelmstedt et al., 2006; Fisher et al., 2008) . Thus, the observed difference between the PGD and IVF data may be explained by the weeks of gestation at which the samples were assessed; women in the PGD group were assessed around 24 weeks, whereas those in the IVF groups were assessed on average at 32 weeks. Prospective studies recruiting both women having PGD and women having IVF only, and measuring antenatal attachment at different times in the pregnancy is needed to generate conclusive data on this issue.
Further discussion is warranted in relation to the absence of a control group in part of this study where we have compared attachment in the PGD sample with that in samples of women who used IVF. This was to explore the emotional adjustment in women who are using similar reproductive technologies, though for the purposes of future research, further consideration and potential discourse with professionals in the field, needs to occur. The debate needs to take account of women's reasons for using ART; women using IVF are generally experiencing organic infertility, which previous research has shown is distressing for long periods of time (e.g. Hart, 2002) , due to the possibility that women may never be able to have their desired child.
Women using PGD for single gene conditions especially, often do not have any experience of infertility, though they may have siblings or children affected by a condition they are trying to avoid, and PGD is used as an alternative to prenatal diagnosis.
It therefore cannot be assumed that the emotional reactions to treatment between these groups would be comparable. On the other hand, women using PGD for aneuploidy screening after failed IVF attempts are intuitively a very appropriate comparison group to women using IVF as both groups of women are experiencing infertility and have the same fears and anxieties about their uncertain reproductive futures. Indeed, no guarantee of success is given to any woman using PGD; however, it is plausible that women using PGD with no history of pregnancy, pregnancy loss or infertility would have less anxiety about the potential for not achieving pregnancy and live birth than women with experience of loss and years of infertility. Future research should focus on selecting appropriate control groups for women using PGD for different reasons.
With the exception of depression as assessed in pregnancy, there were a number of women scoring above the cut-off scores indicative of levels of anxiety and depression that indicate a need for clinical intervention. Future research should focus on strategies of identifying these women and provision of appropriate evidenced-based interventions. Verhaak et al. (2010) have recently developed and trialed an assessment tool, SCREENIVF, based on previously identified predictors of poor emotional adjustment, for use in the IVF setting. Further research into the efficacy of implementing this or similar tools in a PGD population, as well as developing appropriate interventions, is now necessary.
The major limitation of this study is the lack of a comparison group and reliance on archival, previously published comparison data. The study is further limited by the small sample size and the fact that partners were not assessed. The attrition rates were also a limitation and the short time frames for follow-up required in this type of study also need to be considered by future researchers.
Conclusion
Overall, this study suggests that women are emotionally well adjusted entering PGD, as well as at 24 weeks of pregnancy, for those who achieve this. However, significant fluctuations in anxiety and depression during PGD were observed, with some women reporting levels of anxiety and depression on scales at levels of clinical significance. Despite this observed psychological distress in some women, maternal-fetal attachment as assessed at 24 weeks of pregnancy appeared to be sound.
Although results are overall positive for women conceiving after PGD, a subset of women experience a significant emotional burden and these women require closer attention and support. New research should focus on identifying women likely to have maladjustment issues following IVF and the efficacy of using such tools for women undergoing PGD.
